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Background: In STEMI pts impairment of microcirculatory function is a negative independent predictor of myocardial function recovery. In the 
present single-center, prospective randomized substudy we sought to evaluate the impact of manual thrombectomy in STEMI patients undergoing to 
primary angioplasty on DES implantation long term outcome.
Methods: In the EXPIRA Trial we randomized 175 pts (mean age 64.3±10.2 105 male) with a STEMI in order to undergo primary PCI to 
thromboaspiration with a manual device (Export (n=88) (E)) and standard PCI (n=87)(C). The primary end points of the study was the angiographic 
result in terms of MBG ≥ 2 and ST-segment resolution (STr)≥ 70% post-stenting. The secondary end-points were clinical MACEs (cardiac death, re-MI 
and TVR) at 9 and 24 months f-u.
Results: No baseline differences were observed between the two groups except for the incidence of hypertension and cholesterol levels . Presence 
of an high thrombus burden (TS > 3) was observed in all pts.In the total population the incidence of DES implantation was 58.3% (60.9% in the 
E group vs 55.7% in the C group ).After thrombectomy we observed a TIMI II/III flow in 77.0% (C) vs 92.2% (E) (p=0.006). Post-procedural MBG 3 
was 28.7%(C) vs 70.3%(E) (p=<0.0001) and 90’ STrvs 80.0% (E) vs 37.5% (C) (p<.01). At 9-months f-u the incidence of MACE in DES population 
was 15.1%(C) vs 4.2%(E) (p log rank =0.07): cardiac death was7.5% vs 0 (p=0.048); TVR was 4.2 vs 1.8 (p=0.9); no re-MI occurred. After 24 
months MACE free survival was 18.2% vs 4.2 (p log rank=0.031): cardiac death was 10.9% vs 0 (p log rank=0.020); TVR was 4.2% vs 7.2% (p log 
rank=0.47) and re-MI 1.1% vs 0 (p log rank=ns). No definite very late stent thrombosis occurred.Multivariate analysis for MACE showed an HR for 
thromboaspiration and STr (90’)>70% of 0.237 (p<0.031) and 0.237 (p<0.023) respectively.
Conclusions: Compared with conventional stenting, pre-treatment with thrombectomy during primary PCI improves procedural outcomes in terms 
of epicardial flow and microvascular function.Considering the patients treated with primary PCI and DES implantation the pretreatment with manual 
thrombectomy seems to be an independent positive predictor of long term cardiac mortality.
